Data / Form D filings / Eutropics Pharmaceuticals, Inc.
Eutropics Pharmaceuticals, Inc.: Form D filings
Eutropics Pharmaceuticals, Inc., a pharmaceuticals company in Cambridge, MA, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on January 11, 2024, reports an offering of $350,000 with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 767 CONCORD AVENUE, Cambridge, MA, 02138
- Phone
- (617) 714-4405
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1892756
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 11, 2024 | New notice | $350,000 | $0 | $350,000 | 0 | Yet to occur | sec.gov |
| Nov 18, 2021 | New notice | $2,000,000 | $350,000 | $1,650,000 | 5 | Nov 3, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Cardone | Executive Officer, Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Eutropics Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.